Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto Massone is a prominent Argentine pharmaceutical company that specializes in the development and large-scale production of human-derived gonadotropins. Established in 1932, the company has become a global leader in the extraction and purification of hormones such as Menotropin (hMG), Urofollitropin (FSH), and Human Chorionic Gonadotropin (hCG) from natural sources. Their products are essential components in assisted reproductive technology (ART) and the treatment of infertility worldwide. Operating out of advanced facilities in Buenos Aires, the company maintains rigorous GMP standards to supply both active pharmaceutical ingredients (APIs) and finished injectable medications. Instituto Massone serves as a critical supplier to the international fertility market, exporting to numerous countries across several continents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto Massone.